Selected research
Market Analysis & Forecast
Global Biomanufacturing and Fermentation Service Market Analysis and Forecast 2026-2032
Market perspective
The global Biomanufacturing and Fermentation Service market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The North America market for Biomanufacturing and Fermentation Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Biomanufacturing and Fermentation Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Biomanufacturing and Fermentation Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Biomanufacturing and Fermentation Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global companies of Biomanufacturing and Fermentation Service include FUJIFILM Biotechnologies, Elise Biopharma, BOC Sciences, Isomerase Therapeutics, AGC Biologics, Centre for Process Innovation (CPI), Euroapi, 3PBIOVIAN and Abolis Biotechnologies, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for Biomanufacturing and Fermentation Service, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Biomanufacturing and Fermentation Service, also provides the revenue of main regions and countries. Of the upcoming market potential for Biomanufacturing and Fermentation Service, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Biomanufacturing and Fermentation Service revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Biomanufacturing and Fermentation Service market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Biomanufacturing and Fermentation Service revenue, projected growth trends, production technology, application and end-user industry.
Biomanufacturing and Fermentation Service Segment by Company
FUJIFILM Biotechnologies
Elise Biopharma
BOC Sciences
Isomerase Therapeutics
AGC Biologics
Centre for Process Innovation (CPI)
Euroapi
3PBIOVIAN
Abolis Biotechnologies
Evonik
ScaleUp Bio Pte Ltd
Olon Biotech
Biocatalysts Ltd
Manus Bio
ADM
Bio‑Technical Resources
GEA
Lonza
WuXi Biologics
Ajinomoto
BIOVECTRA Inc.
Nordmark Pharma GmbH
Dakota BioWorx
Andgel Industrial (Shanghai) Co
Chengdu Yingde Biomedical
Thermo Fisher Scientific
Asymchem
Danaher
Sartorius
Laurus Bio
Biomanufacturing and Fermentation Service Segment by Type
Strain Engineering Services
Fermentation Process Optimization
Analytical Testing & Quality Control Services
Fermentation CDMO Service
Biomanufacturing and Fermentation Service Segment by Application
Biopharmaceuticals
Industrial Biotechnology
Food and Functional Ingredients
Others
Biomanufacturing and Fermentation Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biomanufacturing and Fermentation Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Biomanufacturing and Fermentation Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biomanufacturing and Fermentation Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Biomanufacturing and Fermentation Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Biomanufacturing and Fermentation Service company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Biomanufacturing and Fermentation Service revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Strain Engineering Services
- Fermentation Process Optimization
- Analytical Testing & Quality Control Services
- Fermentation CDMO Service
Applications
- Biopharmaceuticals
- Industrial Biotechnology
- Food and Functional Ingredients
- Others
Companies covered
- FUJIFILM Biotechnologies
- Elise Biopharma
- BOC Sciences
- Isomerase Therapeutics
- AGC Biologics
- Centre for Process Innovation (CPI)
- Euroapi
- 3PBIOVIAN
- Abolis Biotechnologies
- Evonik
- ScaleUp Bio Pte Ltd
- Olon Biotech
- Biocatalysts Ltd
- Manus Bio
- ADM
- Bio‑Technical Resources
- GEA
- Lonza
- WuXi Biologics
- Ajinomoto
- BIOVECTRA Inc.
- Nordmark Pharma GmbH
- Dakota BioWorx
- Andgel Industrial (Shanghai) Co
- Chengdu Yingde Biomedical
- Thermo Fisher Scientific
- Asymchem
- Danaher
- Sartorius
- Laurus Bio
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Biomanufacturing and Fermentation Service Market by Type
- 1.2.1 Global Biomanufacturing and Fermentation Service Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Strain Engineering Services
- 1.2.3 Fermentation Process Optimization
- 1.2.4 Analytical Testing & Quality Control Services
- 1.2.5 Fermentation CDMO Service
- 1.3 Biomanufacturing and Fermentation Service Market by Application
- 1.3.1 Global Biomanufacturing and Fermentation Service Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Biopharmaceuticals
- 1.3.3 Industrial Biotechnology
- 1.3.4 Food and Functional Ingredients
- 1.3.5 Others
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Biomanufacturing and Fermentation Service Market Dynamics
- 2.1 Biomanufacturing and Fermentation Service Industry Trends
- 2.2 Biomanufacturing and Fermentation Service Industry Drivers
- 2.3 Biomanufacturing and Fermentation Service Industry Opportunities and Challenges
- 2.4 Biomanufacturing and Fermentation Service Industry Restraints
3 Global Growth Perspective
- 3.1 Global Biomanufacturing and Fermentation Service Market Perspective (2021-2032)
- 3.2 Global Biomanufacturing and Fermentation Service Growth Trends by Region
- 3.2.1 Global Biomanufacturing and Fermentation Service Market Size by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Biomanufacturing and Fermentation Service Market Size by Region (2021-2026)
- 3.2.3 Global Biomanufacturing and Fermentation Service Market Size by Region (2027-2032)
4 Competitive Landscape by Players
- 4.1 Global Biomanufacturing and Fermentation Service Revenue by Players
- 4.1.1 Global Biomanufacturing and Fermentation Service Revenue by Players (2021-2026)
- 4.1.2 Global Biomanufacturing and Fermentation Service Revenue Market Share by Players (2021-2026)
- 4.1.3 Global Biomanufacturing and Fermentation Service Players Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Biomanufacturing and Fermentation Service Key Players Ranking, 2024 VS 2025 VS 2026
- 4.3 Global Biomanufacturing and Fermentation Service Key Players Headquarters & Area Served
- 4.4 Global Biomanufacturing and Fermentation Service Players, Product Type & Application
- 4.5 Global Biomanufacturing and Fermentation Service Players Establishment Date
- 4.6 Market Competitive Analysis
- 4.6.1 Global Biomanufacturing and Fermentation Service Market CR5 and HHI
- 4.6.3 2025 Biomanufacturing and Fermentation Service Tier 1, Tier 2, and Tier 3
5 Biomanufacturing and Fermentation Service Market Size by Type
- 5.1 Global Biomanufacturing and Fermentation Service Revenue by Type (2021 VS 2025 VS 2032)
- 5.2 Global Biomanufacturing and Fermentation Service Revenue by Type (2021-2032)
- 5.3 Global Biomanufacturing and Fermentation Service Revenue Market Share by Type (2021-2032)
6 Biomanufacturing and Fermentation Service Market Size by Application
- 6.1 Global Biomanufacturing and Fermentation Service Revenue by Application (2021 VS 2025 VS 2032)
- 6.2 Global Biomanufacturing and Fermentation Service Revenue by Application (2021-2032)
- 6.3 Global Biomanufacturing and Fermentation Service Revenue Market Share by Application (2021-2032)
7 Company Profiles
- 7.1 FUJIFILM Biotechnologies
- 7.1.1 FUJIFILM Biotechnologies Company Information
- 7.1.2 FUJIFILM Biotechnologies Business Overview
- 7.1.3 FUJIFILM Biotechnologies Biomanufacturing and Fermentation Service Revenue and Gross Margin (2021-2026)
- 7.1.4 FUJIFILM Biotechnologies Biomanufacturing and Fermentation Service Product Portfolio
- 7.1.5 FUJIFILM Biotechnologies Recent Developments
- 7.2 Elise Biopharma
- 7.2.1 Elise Biopharma Company Information
- 7.2.2 Elise Biopharma Business Overview
- 7.2.3 Elise Biopharma Biomanufacturing and Fermentation Service Revenue and Gross Margin (2021-2026)
- 7.2.4 Elise Biopharma Biomanufacturing and Fermentation Service Product Portfolio
- 7.2.5 Elise Biopharma Recent Developments
- 7.3 BOC Sciences
- 7.3.1 BOC Sciences Company Information
- 7.3.2 BOC Sciences Business Overview
- 7.3.3 BOC Sciences Biomanufacturing and Fermentation Service Revenue and Gross Margin (2021-2026)
- 7.3.4 BOC Sciences Biomanufacturing and Fermentation Service Product Portfolio
- 7.3.5 BOC Sciences Recent Developments
- 7.4 Isomerase Therapeutics
- 7.4.1 Isomerase Therapeutics Company Information
- 7.4.2 Isomerase Therapeutics Business Overview
- 7.4.3 Isomerase Therapeutics Biomanufacturing and Fermentation Service Revenue and Gross Margin (2021-2026)
- 7.4.4 Isomerase Therapeutics Biomanufacturing and Fermentation Service Product Portfolio
- 7.4.5 Isomerase Therapeutics Recent Developments
- 7.5 AGC Biologics
- 7.5.1 AGC Biologics Company Information
- 7.5.2 AGC Biologics Business Overview
- 7.5.3 AGC Biologics Biomanufacturing and Fermentation Service Revenue and Gross Margin (2021-2026)
- 7.5.4 AGC Biologics Biomanufacturing and Fermentation Service Product Portfolio
- 7.5.5 AGC Biologics Recent Developments
- 7.6 Centre for Process Innovation (CPI)
- 7.6.1 Centre for Process Innovation (CPI) Company Information
- 7.6.2 Centre for Process Innovation (CPI) Business Overview
- 7.6.3 Centre for Process Innovation (CPI) Biomanufacturing and Fermentation Service Revenue and Gross Margin (2021-2026)
- 7.6.4 Centre for Process Innovation (CPI) Biomanufacturing and Fermentation Service Product Portfolio
- 7.6.5 Centre for Process Innovation (CPI) Recent Developments
- 7.7 Euroapi
- 7.7.1 Euroapi Company Information
- 7.7.2 Euroapi Business Overview
- 7.7.3 Euroapi Biomanufacturing and Fermentation Service Revenue and Gross Margin (2021-2026)
- 7.7.4 Euroapi Biomanufacturing and Fermentation Service Product Portfolio
- 7.7.5 Euroapi Recent Developments
- 7.8 3PBIOVIAN
- 7.8.1 3PBIOVIAN Company Information
- 7.8.2 3PBIOVIAN Business Overview
- 7.8.3 3PBIOVIAN Biomanufacturing and Fermentation Service Revenue and Gross Margin (2021-2026)
- 7.8.4 3PBIOVIAN Biomanufacturing and Fermentation Service Product Portfolio
- 7.8.5 3PBIOVIAN Recent Developments
- 7.9 Abolis Biotechnologies
- 7.9.1 Abolis Biotechnologies Company Information
- 7.9.2 Abolis Biotechnologies Business Overview
- 7.9.3 Abolis Biotechnologies Biomanufacturing and Fermentation Service Revenue and Gross Margin (2021-2026)
- 7.9.4 Abolis Biotechnologies Biomanufacturing and Fermentation Service Product Portfolio
- 7.9.5 Abolis Biotechnologies Recent Developments
- 7.10 Evonik
- 7.10.1 Evonik Company Information
- 7.10.2 Evonik Business Overview
- 7.10.3 Evonik Biomanufacturing and Fermentation Service Revenue and Gross Margin (2021-2026)
- 7.10.4 Evonik Biomanufacturing and Fermentation Service Product Portfolio
- 7.10.5 Evonik Recent Developments
- 7.11 ScaleUp Bio Pte Ltd
- 7.11.1 ScaleUp Bio Pte Ltd Company Information
- 7.11.2 ScaleUp Bio Pte Ltd Business Overview
- 7.11.3 ScaleUp Bio Pte Ltd Biomanufacturing and Fermentation Service Revenue and Gross Margin (2021-2026)
- 7.11.4 ScaleUp Bio Pte Ltd Biomanufacturing and Fermentation Service Product Portfolio
- 7.11.5 ScaleUp Bio Pte Ltd Recent Developments
- 7.12 Olon Biotech
- 7.12.1 Olon Biotech Company Information
- 7.12.2 Olon Biotech Business Overview
- 7.12.3 Olon Biotech Biomanufacturing and Fermentation Service Revenue and Gross Margin (2021-2026)
- 7.12.4 Olon Biotech Biomanufacturing and Fermentation Service Product Portfolio
- 7.12.5 Olon Biotech Recent Developments
- 7.13 Biocatalysts Ltd
- 7.13.1 Biocatalysts Ltd Company Information
- 7.13.2 Biocatalysts Ltd Business Overview
- 7.13.3 Biocatalysts Ltd Biomanufacturing and Fermentation Service Revenue and Gross Margin (2021-2026)
- 7.13.4 Biocatalysts Ltd Biomanufacturing and Fermentation Service Product Portfolio
- 7.13.5 Biocatalysts Ltd Recent Developments
- 7.14 Manus Bio
- 7.14.1 Manus Bio Company Information
- 7.14.2 Manus Bio Business Overview
- 7.14.3 Manus Bio Biomanufacturing and Fermentation Service Revenue and Gross Margin (2021-2026)
- 7.14.4 Manus Bio Biomanufacturing and Fermentation Service Product Portfolio
- 7.14.5 Manus Bio Recent Developments
- 7.15 ADM
- 7.15.1 ADM Company Information
- 7.15.2 ADM Business Overview
- 7.15.3 ADM Biomanufacturing and Fermentation Service Revenue and Gross Margin (2021-2026)
- 7.15.4 ADM Biomanufacturing and Fermentation Service Product Portfolio
- 7.15.5 ADM Recent Developments
- 7.16 Bio‑Technical Resources
- 7.16.1 Bio‑Technical Resources Company Information
- 7.16.2 Bio‑Technical Resources Business Overview
- 7.16.3 Bio‑Technical Resources Biomanufacturing and Fermentation Service Revenue and Gross Margin (2021-2026)
- 7.16.4 Bio‑Technical Resources Biomanufacturing and Fermentation Service Product Portfolio
- 7.16.5 Bio‑Technical Resources Recent Developments
- 7.17 GEA
- 7.17.1 GEA Company Information
- 7.17.2 GEA Business Overview
- 7.17.3 GEA Biomanufacturing and Fermentation Service Revenue and Gross Margin (2021-2026)
- 7.17.4 GEA Biomanufacturing and Fermentation Service Product Portfolio
- 7.17.5 GEA Recent Developments
- 7.18 Lonza
- 7.18.1 Lonza Company Information
- 7.18.2 Lonza Business Overview
- 7.18.3 Lonza Biomanufacturing and Fermentation Service Revenue and Gross Margin (2021-2026)
- 7.18.4 Lonza Biomanufacturing and Fermentation Service Product Portfolio
- 7.18.5 Lonza Recent Developments
- 7.19 WuXi Biologics
- 7.19.1 WuXi Biologics Company Information
- 7.19.2 WuXi Biologics Business Overview
- 7.19.3 WuXi Biologics Biomanufacturing and Fermentation Service Revenue and Gross Margin (2021-2026)
- 7.19.4 WuXi Biologics Biomanufacturing and Fermentation Service Product Portfolio
- 7.19.5 WuXi Biologics Recent Developments
- 7.20 Ajinomoto
- 7.20.1 Ajinomoto Company Information
- 7.20.2 Ajinomoto Business Overview
- 7.20.3 Ajinomoto Biomanufacturing and Fermentation Service Revenue and Gross Margin (2021-2026)
- 7.20.4 Ajinomoto Biomanufacturing and Fermentation Service Product Portfolio
- 7.20.5 Ajinomoto Recent Developments
- 7.21 BIOVECTRA Inc.
- 7.21.1 BIOVECTRA Inc. Company Information
- 7.21.2 BIOVECTRA Inc. Business Overview
- 7.21.3 BIOVECTRA Inc. Biomanufacturing and Fermentation Service Revenue and Gross Margin (2021-2026)
- 7.21.4 BIOVECTRA Inc. Biomanufacturing and Fermentation Service Product Portfolio
- 7.21.5 BIOVECTRA Inc. Recent Developments
- 7.22 Nordmark Pharma GmbH
- 7.22.1 Nordmark Pharma GmbH Company Information
- 7.22.2 Nordmark Pharma GmbH Business Overview
- 7.22.3 Nordmark Pharma GmbH Biomanufacturing and Fermentation Service Revenue and Gross Margin (2021-2026)
- 7.22.4 Nordmark Pharma GmbH Biomanufacturing and Fermentation Service Product Portfolio
- 7.22.5 Nordmark Pharma GmbH Recent Developments
- 7.23 Dakota BioWorx
- 7.23.1 Dakota BioWorx Company Information
- 7.23.2 Dakota BioWorx Business Overview
- 7.23.3 Dakota BioWorx Biomanufacturing and Fermentation Service Revenue and Gross Margin (2021-2026)
- 7.23.4 Dakota BioWorx Biomanufacturing and Fermentation Service Product Portfolio
- 7.23.5 Dakota BioWorx Recent Developments
- 7.24 Andgel Industrial (Shanghai) Co
- 7.24.1 Andgel Industrial (Shanghai) Co Company Information
- 7.24.2 Andgel Industrial (Shanghai) Co Business Overview
- 7.24.3 Andgel Industrial (Shanghai) Co Biomanufacturing and Fermentation Service Revenue and Gross Margin (2021-2026)
- 7.24.4 Andgel Industrial (Shanghai) Co Biomanufacturing and Fermentation Service Product Portfolio
- 7.24.5 Andgel Industrial (Shanghai) Co Recent Developments
- 7.25 Chengdu Yingde Biomedical
- 7.25.1 Chengdu Yingde Biomedical Company Information
- 7.25.2 Chengdu Yingde Biomedical Business Overview
- 7.25.3 Chengdu Yingde Biomedical Biomanufacturing and Fermentation Service Revenue and Gross Margin (2021-2026)
- 7.25.4 Chengdu Yingde Biomedical Biomanufacturing and Fermentation Service Product Portfolio
- 7.25.5 Chengdu Yingde Biomedical Recent Developments
- 7.26 Thermo Fisher Scientific
- 7.26.1 Thermo Fisher Scientific Company Information
- 7.26.2 Thermo Fisher Scientific Business Overview
- 7.26.3 Thermo Fisher Scientific Biomanufacturing and Fermentation Service Revenue and Gross Margin (2021-2026)
- 7.26.4 Thermo Fisher Scientific Biomanufacturing and Fermentation Service Product Portfolio
- 7.26.5 Thermo Fisher Scientific Recent Developments
- 7.27 Asymchem
- 7.27.1 Asymchem Company Information
- 7.27.2 Asymchem Business Overview
- 7.27.3 Asymchem Biomanufacturing and Fermentation Service Revenue and Gross Margin (2021-2026)
- 7.27.4 Asymchem Biomanufacturing and Fermentation Service Product Portfolio
- 7.27.5 Asymchem Recent Developments
- 7.28 Danaher
- 7.28.1 Danaher Company Information
- 7.28.2 Danaher Business Overview
- 7.28.3 Danaher Biomanufacturing and Fermentation Service Revenue and Gross Margin (2021-2026)
- 7.28.4 Danaher Biomanufacturing and Fermentation Service Product Portfolio
- 7.28.5 Danaher Recent Developments
- 7.29 Sartorius
- 7.29.1 Sartorius Company Information
- 7.29.2 Sartorius Business Overview
- 7.29.3 Sartorius Biomanufacturing and Fermentation Service Revenue and Gross Margin (2021-2026)
- 7.29.4 Sartorius Biomanufacturing and Fermentation Service Product Portfolio
- 7.29.5 Sartorius Recent Developments
- 7.30 Laurus Bio
- 7.30.1 Laurus Bio Company Information
- 7.30.2 Laurus Bio Business Overview
- 7.30.3 Laurus Bio Biomanufacturing and Fermentation Service Revenue and Gross Margin (2021-2026)
- 7.30.4 Laurus Bio Biomanufacturing and Fermentation Service Product Portfolio
- 7.30.5 Laurus Bio Recent Developments
8 North America
- 8.1 North America Biomanufacturing and Fermentation Service Revenue (2021-2032)
- 8.2 North America Biomanufacturing and Fermentation Service Revenue by Type (2021-2032)
- 8.2.1 North America Biomanufacturing and Fermentation Service Revenue by Type (2021-2026)
- 8.2.2 North America Biomanufacturing and Fermentation Service Revenue by Type (2027-2032)
- 8.3 North America Biomanufacturing and Fermentation Service Revenue Share by Type (2021-2032)
- 8.4 North America Biomanufacturing and Fermentation Service Revenue by Application (2021-2032)
- 8.4.1 North America Biomanufacturing and Fermentation Service Revenue by Application (2021-2026)
- 8.4.2 North America Biomanufacturing and Fermentation Service Revenue by Application (2027-2032)
- 8.5 North America Biomanufacturing and Fermentation Service Revenue Share by Application (2021-2032)
- 8.6 North America Biomanufacturing and Fermentation Service Revenue by Country
- 8.6.1 North America Biomanufacturing and Fermentation Service Revenue by Country (2021 VS 2025 VS 2032)
- 8.6.2 North America Biomanufacturing and Fermentation Service Revenue by Country (2021-2026)
- 8.6.3 North America Biomanufacturing and Fermentation Service Revenue by Country (2027-2032)
- 8.6.4 United States
- 8.6.5 Canada
- 8.6.6 Mexico
9 Europe
- 9.1 Europe Biomanufacturing and Fermentation Service Revenue (2021-2032)
- 9.2 Europe Biomanufacturing and Fermentation Service Revenue by Type (2021-2032)
- 9.2.1 Europe Biomanufacturing and Fermentation Service Revenue by Type (2021-2026)
- 9.2.2 Europe Biomanufacturing and Fermentation Service Revenue by Type (2027-2032)
- 9.3 Europe Biomanufacturing and Fermentation Service Revenue Share by Type (2021-2032)
- 9.4 Europe Biomanufacturing and Fermentation Service Revenue by Application (2021-2032)
- 9.4.1 Europe Biomanufacturing and Fermentation Service Revenue by Application (2021-2026)
- 9.4.2 Europe Biomanufacturing and Fermentation Service Revenue by Application (2027-2032)
- 9.5 Europe Biomanufacturing and Fermentation Service Revenue Share by Application (2021-2032)
- 9.6 Europe Biomanufacturing and Fermentation Service Revenue by Country
- 9.6.1 Europe Biomanufacturing and Fermentation Service Revenue by Country (2021 VS 2025 VS 2032)
- 9.6.2 Europe Biomanufacturing and Fermentation Service Revenue by Country (2021-2026)
- 9.6.3 Europe Biomanufacturing and Fermentation Service Revenue by Country (2027-2032)
- 9.6.4 Germany
- 9.6.5 France
- 9.6.6 U.K.
- 9.6.7 Italy
- 9.6.8 Russia
- 9.6.9 Spain
- 9.6.10 Netherlands
- 9.6.11 Switzerland
- 9.6.12 Sweden
- 9.6.13 Poland
10 China
- 10.1 China Biomanufacturing and Fermentation Service Revenue (2021-2032)
- 10.2 China Biomanufacturing and Fermentation Service Revenue by Type (2021-2032)
- 10.2.1 China Biomanufacturing and Fermentation Service Revenue by Type (2021-2026)
- 10.2.2 China Biomanufacturing and Fermentation Service Revenue by Type (2027-2032)
- 10.3 China Biomanufacturing and Fermentation Service Revenue Share by Type (2021-2032)
- 10.4 China Biomanufacturing and Fermentation Service Revenue by Application (2021-2032)
- 10.4.1 China Biomanufacturing and Fermentation Service Revenue by Application (2021-2026)
- 10.4.2 China Biomanufacturing and Fermentation Service Revenue by Application (2027-2032)
- 10.5 China Biomanufacturing and Fermentation Service Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Biomanufacturing and Fermentation Service Revenue (2021-2032)
- 11.2 Asia Biomanufacturing and Fermentation Service Revenue by Type (2021-2032)
- 11.2.1 Asia Biomanufacturing and Fermentation Service Revenue by Type (2021-2026)
- 11.2.2 Asia Biomanufacturing and Fermentation Service Revenue by Type (2027-2032)
- 11.3 Asia Biomanufacturing and Fermentation Service Revenue Share by Type (2021-2032)
- 11.4 Asia Biomanufacturing and Fermentation Service Revenue by Application (2021-2032)
- 11.4.1 Asia Biomanufacturing and Fermentation Service Revenue by Application (2021-2026)
- 11.4.2 Asia Biomanufacturing and Fermentation Service Revenue by Application (2027-2032)
- 11.5 Asia Biomanufacturing and Fermentation Service Revenue Share by Application (2021-2032)
- 11.6 Asia Biomanufacturing and Fermentation Service Revenue by Country
- 11.6.1 Asia Biomanufacturing and Fermentation Service Revenue by Country (2021 VS 2025 VS 2032)
- 11.6.2 Asia Biomanufacturing and Fermentation Service Revenue by Country (2021-2026)
- 11.6.3 Asia Biomanufacturing and Fermentation Service Revenue by Country (2027-2032)
- 11.6.4 Japan
- 11.6.5 South Korea
- 11.6.6 India
- 11.6.7 Australia
- 11.6.8 Taiwan
- 11.6.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Biomanufacturing and Fermentation Service Revenue (2021-2032)
- 12.2 SAMEA Biomanufacturing and Fermentation Service Revenue by Type (2021-2032)
- 12.2.1 SAMEA Biomanufacturing and Fermentation Service Revenue by Type (2021-2026)
- 12.2.2 SAMEA Biomanufacturing and Fermentation Service Revenue by Type (2027-2032)
- 12.3 SAMEA Biomanufacturing and Fermentation Service Revenue Share by Type (2021-2032)
- 12.4 SAMEA Biomanufacturing and Fermentation Service Revenue by Application (2021-2032)
- 12.4.1 SAMEA Biomanufacturing and Fermentation Service Revenue by Application (2021-2026)
- 12.4.2 SAMEA Biomanufacturing and Fermentation Service Revenue by Application (2027-2032)
- 12.5 SAMEA Biomanufacturing and Fermentation Service Revenue Share by Application (2021-2032)
- 12.6 SAMEA Biomanufacturing and Fermentation Service Revenue by Country
- 12.6.1 SAMEA Biomanufacturing and Fermentation Service Revenue by Country (2021 VS 2025 VS 2032)
- 12.6.2 SAMEA Biomanufacturing and Fermentation Service Revenue by Country (2021-2026)
- 12.6.3 SAMEA Biomanufacturing and Fermentation Service Revenue by Country (2027-2032)
- 12.6.4 Brazil
- 12.6.5 Argentina
- 12.6.6 Chile
- 12.6.7 Colombia
- 12.6.8 Peru
- 12.6.9 Saudi Arabia
- 12.6.10 Israel
- 12.6.11 UAE
- 12.6.12 Turkey
- 12.6.13 Iran
- 12.6.14 Egypt
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst